相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Study of ΔNp63 Expression in Lung Non-Small Cell Carcinomas
Daisuke Nonaka
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: A novel ALK fusion gene?
Morio Yamamoto et al.
CANCER SCIENCE (2012)
The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma
Michael H. Roh et al.
DIAGNOSTIC CYTOPATHOLOGY (2012)
ALK-Rearranged Lung Cancer Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma
Jamie E. Chaft et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer A Novel Two-Hit, Sparing-Material Approach
Giuseppe Pelosi et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
Justin A. Bishop et al.
MODERN PATHOLOGY (2012)
Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas
Songmi Noh et al.
LUNG CANCER (2012)
KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only
Yuki Togashi et al.
PLOS ONE (2012)
A 6-Antibody Panel for the Classification of Lung Adenocarcinoma Versus Squamous Cell Carcinoma
David Tacha et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Desmoglein-3 and Napsin A Double Stain, a Useful Immunohistochemical Marker for Differentiation of Lung Squamous Cell Carcinoma and Adenocarcinoma From Other Subtypes
Yetkin Agackiran et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Usefulness of Immunohistochemical and Histochemical Studies in the Classification of Lung Adenocarcinoma and Squamous Cell Carcinoma in Cytologic Specimens
Rebecca Ocque et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas
Akihiko Yoshida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6
Sanjay Mukhopadhyay et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Immunohistochemical Subtyping of Nonsmall Cell Lung Cancer Not Otherwise Specified in Fine-Needle Aspiration Cytology A Retrospective Study of 103 Cases With Surgical Correlation
Luisella Righi et al.
CANCER (2011)
A Novel KIF5B-ALK Variant in Nonsmall Cell Lung Cancer
Daisy Wing-Sze Wong et al.
CANCER (2011)
Comparison of the Expression Levels of Napsin A, Thyroid Transcription Factor-1, and p63 in Nonsmall Cell Lung Cancer Using Cytocentrifuged Bronchial Brushings
Emiko Aikawa et al.
CANCER CYTOPATHOLOGY (2011)
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers
Samuel J. Klempner et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Utility of 10 Immunohistochemical Markers Including Novel Markers (Desmocollin-3, Glypican 3, S100A2, S100A7, and Sox-2) for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung
Koji Tsuta et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens
Giuseppe Pelosi et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens
Natasha Rekhtman et al.
MODERN PATHOLOGY (2011)
The Diagnostic Value of Cytokeratin 5/6, 14, 17, and 18 Expression in Human Non-Small Cell Lung Cancer
Yuan Chen et al.
ONCOLOGY (2011)
Rapid Multiplex Immunohistochemistry Using the 4-antibody Cocktail YANA-4 in Differentiating Primary Adenocarcinoma From Squamous Cell Carcinoma of the Lung
Emmy Yanagita et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma
Ryu Jokoji et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Role of Desmoglein-3 in the Diagnosis of Squamous Cell Carcinoma of the Lung
Cemile Dilara Savci-Heijink et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The EML4-ALK Fusion Gene Is Involved in Various Histologic Types of Lung Cancers From Nonsmokers With Wild-type EGFR and KRAS
Daisy Wing-Sze Wong et al.
CANCER (2009)
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2009)
A Reevaluation of the Clinical Significance of Histological Subtyping of Non-Small-Cell Lung Carcinoma: Diagnostic Algorithms in the Era of Personalized Treatments
Giulio Rossi et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2009)
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung
Valentina Monica et al.
MODERN PATHOLOGY (2009)
A novel five-antibody immunohistochemical test for subclassification of lung carcinoma
Brian Z. Ring et al.
MODERN PATHOLOGY (2009)
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
Kentaro Inamura et al.
MODERN PATHOLOGY (2009)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers
Kentaro Inamura et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification
B. Angulo et al.
JOURNAL OF PATHOLOGY (2008)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
DH Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Keratin expression in human tissues and neoplasms
PG Chu et al.
HISTOPATHOLOGY (2002)
Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas
MH Lyda et al.
HUMAN PATHOLOGY (2000)
分享论文
